Investing.com India12m
Morgan Stanley upgrades Zealand Pharma to Buy on ’long-term obesity potential’
Investing.com -- Morgan Stanley (NYSE: MS) upgraded its rating on Zealand Pharma (NASDAQ: ZEAL) shares to Overweight from ...
Popular Type 2 diabetes medicine Mounjaro released in India
Eli Lilly launches Mounjaro in India addressing diabetes-obesity crisis. Approved by CDSCO yet high costs limit accessibility ...
Weight-loss drug Mounjaro in India: Is it better than Ozempic?
US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...
Mounjaro vs. Ozempic: Which is more effective?
The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...